NORTHWEST BIOTHERAPEUTICS, INC. FORM of WARRANT
THIS
WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED
FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR UNLESS SUCH TRANSACTION IS IN
COMPLIANCE WITH APPLICABLE FEDERAL AND STATE SECURITIES LAWS.
NORTHWEST
BIOTHERAPEUTICS, INC.
FORM
of WARRANT
No.
BW-2009-__
|
___________,
2009
|
This
Certifies That, for value received, ____________ and/or its assigns
(collectively, the “Holder”),
is entitled to subscribe for and purchase from Northwest
Biotherapeutics, Inc., a Delaware corporation, with its principal office
in Bethesda, Maryland (the “Company”),
such number of Exercise Shares as provided herein at the Exercise Price as
provided herein. This Warrant is being issued conditional upon, and pursuant to
the terms and conditions of, that certain Stock Purchase Agreement of even date
herewith (the Stock Purchase Agreement”), by and among the Company and Holder
(the “Note”).
1. Definitions.
Capitalized terms used but not defined herein shall have the meanings set
forth in the Note, as applicable. As used herein, the following terms shall have
the following respective meanings:
(a) “Common Stock”
shall mean the common stock of the Company, par value $0.001 per
share.
(b) “Exercise
Period” shall mean the period commencing on the date of issuance of this
Warrant and ending five (5) years after the date of issuance of this
Warrant.
(c) “Exercise
Price” of this Warrant shall be equal to ____________ ($___) per share,
subject to adjustment as provided herein.
(d) “Exercise
Share” shall mean each of
the ______________________ (xxx,xxx) shares of Common Stock for which this
Warrant is exercisable.
2.
Exercise of
Warrant. This Warrant will be fully vested and exercisable upon
issuance. The rights represented by this Warrant may be exercised in
whole or in part at any time or times during the Exercise Period, by delivery of
the following to the Company at its address set forth above (or at such other
address as it may designate by notice in writing to the Holder):
(a) An
executed Notice of Exercise in the form attached hereto;
(b) Payment
of the Exercise Price either (i) in cash or by check, or (ii) by cancellation of
indebtedness; and
1.
(c) This
Warrant.
Upon the
exercise of the rights represented by this Warrant, a certificate or
certificates for the Exercise Shares so purchased, registered in the name of the
Holder or Xxxxxx’s designee(s), shall be issued and delivered to the Holder
within a reasonable time after the rights represented by this Warrant shall have
been so exercised. In the event that this Warrant is being exercised for less
than all of the then-current number of Exercise Shares purchasable hereunder,
the Company shall, concurrently with the issuance by the Company of the number
of Exercise Shares for which this Warrant is then being exercised, issue a new
Warrant exercisable for the remaining number of Exercise Shares purchasable
hereunder.
The
person in whose name any certificate or certificates for Exercise Shares are to
be issued upon exercise of this Warrant shall be deemed to have become the
holder of record of such shares on the date on which this Warrant was
surrendered and payment of the Exercise Price was made, irrespective of the date
of delivery of such certificate or certificates, except that, if the date of
such surrender and payment is a date when the stock transfer books of the
Company are closed, such person shall be deemed to have become the holder of
such shares at the close of business on the next succeeding date on which the
stock transfer books are open.
2.1 Net (Cashless) Exercise.
Notwithstanding any provisions herein to the contrary, if the fair market value
of one Exercise Share is greater than the Exercise Price (at the date of
calculation as set forth below), in lieu of exercising this Warrant by payment
of cash, the Holder may elect to receive shares equal to the value (as
determined below) of this Warrant (or the portion thereof being canceled) by
surrender of this Warrant at the principal office of the Company together with
the properly endorsed Notice of Exercise in which event the Company shall issue
to the Holder a number of Exercise Shares computed using the following
formula:
X = Y (A-B)
A
|
Where X =
|
the
number of Exercise Shares to be issued to the
Holder
|
|
Y
=
|
the
number of Exercise Shares purchasable under the Warrant or, if only a
portion of the Warrant is being exercised, that portion of the Warrant
being canceled (at the date of such
calculation)
|
|
A
=
|
the
fair market value of one Exercise Share (at the date of such
calculation)
|
|
B
=
|
Exercise
Price (as adjusted to the date of such
calculation)
|
For
purposes of the above calculation, the fair market value of one Exercise Share
shall be determined by the Company’s Board of Directors in good faith; provided,
however, that in the event that this Warrant is exercised pursuant to this
Section 2.1 in connection with a public offering
of Common Stock, the fair market value per share shall be the per
share offering price to the public in such public
offering.
2.
2.2 Securities for Which Warrant is
Exercisable. This Warrant shall be exercisable, in whole or in part, and
from time to time, for Common Stock of the Company.
3.
Covenants of the Company.
3.1 Covenants as to Exercise
Shares. The Company covenants and agrees that all Exercise Shares that
may be issued upon the exercise of the rights represented by this Warrant will,
upon issuance, be validly issued and outstanding, fully paid and nonassessable,
and free from all taxes, liens and charges with respect to the issuance thereof.
The Company further covenants and agrees that the Company will at all times
during the Exercise Period, have authorized and reserved, free from preemptive
rights, a sufficient number of shares of Common Stock to provide for the
exercise of the rights represented by this Warrant. If at any time
during the Exercise Period the number of authorized but unissued shares of
Common Stock shall not be sufficient to permit exercise of this Warrant, then,
in addition to such other remedies as may be available to Holder, including,
without limitation, pursuant to the Note, the Company will take such corporate
action as shall be necessary to increase its authorized but unissued shares of
Common Stock to such number of shares as shall be sufficient for such
purposes.
3.2 Notices of Record Date. In the
event of any taking by the Company of a record of the holders of any class of
securities for the purpose of determining the holders thereof who are entitled
to receive any dividend or other distribution, the Company shall mail to the
Holder, at least ten (10) days prior to the date specified herein, a notice
specifying the date on which any such record is to be taken for the purpose of
such dividend or distribution.
3.3 No Impairment. The
Holder’s rights, preferences and privileges granted under and/or in connection
with this Warrant may not be amended, modified or waived without the Holder’s
prior written consent.
3.4 Registration
Rights. The Company will use commercially reasonable best
efforts to provide the Holder with “piggyback” registration rights for the
Exercise Shares under the same terms and conditions as provided in the Stock
Purchase Agreement, pursuant to the Securities Act of 1933, as amended (the
“Act”).
4. Representations
of Holder.
4.1 Acquisition of Warrant for Personal
Account. The Holder represents and warrants that it is acquiring the
Warrant and the Exercise Shares solely for its account for investment and not
with a view to or for sale or distribution of said Warrant or Exercise Shares,
or any part thereof, except in compliance with applicable federal and state
securities laws. The Holder also represents and warrants that the all legal and
beneficial interests in the Warrant and the Exercise Shares which the Holder is
acquiring are being acquired for, and will be held for, its account
only.
4.2 Securities
Are Not Registered.
(a) The
Holder understands that the Warrant and the Exercise Shares have not been
registered under the Act on the basis that no distribution or public offering of
the stock of the Company is to be effected by the Holder. The Holder realizes
that the basis for the exemption may not be present if, notwithstanding its
representations, the Holder has a present intention of acquiring the securities
for a fixed or determinable period in the future, selling (in connection with a
distribution or otherwise), granting any participation in, or otherwise
distributing the securities. The Holder represents and warrants that it has no
such present intention.
3.
(b) The
Holder recognizes that the Warrant and the Exercise Shares must be held
indefinitely unless they are subsequently registered under the Act or an
exemption from such registration is available.
(c) The
Holder is aware that neither the Warrant nor the Exercise Shares may be sold
pursuant to Rule 144 adopted under the Act unless certain conditions are met,
including, among other things, the availability of certain current public
information about the Company, the resale following the required holding period
under Rule 144 and the number of shares being sold during any three month period
not exceeding specified limitations.
4.3 Legends.
The Holder understands and agrees that
all certificates evidencing the shares to be issued to the Holder may bear the
following legend:
THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”). THEY MAY
NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE ACT OR UNLESS
SUCH TRANSACTION IS IN COMPLIANCE WITH APPLICABLE FEDERAL AND STATE SECURITIES
LAWS.
4.4 Accredited Investor Status.
The Holder is an “accredited investor” as defined in Regulation D
promulgated under the Act.
5.
Adjustment of Exercise Price and
Exercise Shares.
5.1 Changes in
Securities. In the event of changes in the
Common Stock by reason of stock dividends, splits, recapitalizations,
reclassifications, combinations or exchanges of shares, separations,
reorganizations, liquidations, or the like, the number of Exercise Shares
available under the Warrant in the aggregate and the Exercise Price shall be
correspondingly adjusted to give the Holder of the Warrant, on exercise for the
same aggregate Exercise Price, the same shares as the Holder would have owned
had the Warrant been exercised prior to the event and had the Holder continued
to hold such shares until after the event requiring adjustment. For purposes of
this Section 5, the “Aggregate
Exercise Price” shall mean the aggregate Exercise Price payable in
connection with the exercise in full of this Warrant. The form of this Warrant
need not be changed because of any adjustment in the number of Exercise Shares
subject to this Warrant.
5.2 Certificate of Adjustments.
Upon each adjustment of the Exercise Price and/or Exercise Shares, the
Company shall promptly notify the Holder in writing and furnish the Holder with
a certificate of its Chief Executive Officer or Chief Financial Officer setting
forth such adjustment and the facts upon which such adjustment is
based.
4.
6.
Fractional
Shares. No fractional shares shall be issued upon the exercise of this
Warrant as a consequence of any adjustment pursuant hereto. All Exercise Shares
(including fractions) to be issued upon exercise of this Warrant shall be
aggregated for purposes of determining whether the exercise would result in the
issuance of any fractional share. If, after aggregation, the exercise would
result in the issuance of a fractional share, the Company shall, in lieu of
issuance of any fractional share, pay the Holder otherwise entitled to such
fraction a sum in cash equal to the product resulting from multiplying the then
current fair market value of one Exercise Share by such fraction.
7.
Transfer of
Warrant. Subject to applicable laws, this Warrant and all rights
hereunder are transferable, in whole or in part, to the extent permitted under
applicable securities laws, at any time or times by the Holder, upon delivery of
this Warrant and the form of assignment attached hereto to any transferee
designated by Xxxxxx. The transferee shall sign a customary investment letter in
form and substance reasonably satisfactory to the Company.
8.
Lost,
Stolen, Mutilated or Destroyed Warrant. If this Warrant is lost, stolen,
mutilated or destroyed, the Company may, on such terms as to indemnity or
otherwise as it may reasonably impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like
denomination and tenor as the Warrant so lost, stolen, mutilated or destroyed.
Any such new Warrant shall constitute an original contractual obligation of the
Company, whether or not the allegedly lost, stolen, mutilated or destroyed
Warrant shall be at any time enforceable by anyone.
9.
Amendment. Any term of this Warrant may
be amended or waived only with the written consent of the Company and the
Holder.
10. Notices,
etc. All notices required or permitted hereunder shall be in writing and
shall be deemed effectively given upon actual delivery to the
recipient. All communications shall be sent to the Company and to the
Holder at the addresses set forth herein or in the Stock Purchase Agreement, or
at such other address as the Company or Holder may designate by written notice
to the other parties hereto.
11. Governing
Law. This Warrant and all rights, obligations and liabilities hereunder
shall be governed by and construed under the laws of the State of Delaware as
applied to agreements among Delaware residents, made and to be performed
entirely within the State of Delaware without giving effect to conflicts of laws
principles.
[Signature
Page Follows]
5.
In Witness
Whereof, the Company has caused this Warrant to be executed by its duly
authorized officer as of the date first written above.
Northwest
Biotherapeutics, Inc.
|
|
By:
|
|
Name:
Xxxxx Xxxxxxx
|
|
Title:
President
|
Address: 0000
Xxxxxxxxx Xxx
Suite 750
Bethesda, MD 20814
Holder:___________________________________________
By:
|
|
Name:
|
|
Title:
|
|
Address:
|
[Signature
Page to Warrant No. BW-2009-___]
NOTICE
OF EXERCISE
TO:
Northwest Biotherapeutics, Inc.
(1) ¨
The undersigned hereby elects to purchase ________ shares of Common Stock (the
“Exercise
Shares”) of Northwest
Biotherapeutics,
Inc. (the “Company”)
pursuant to the terms of the attached Warrant, and tenders herewith payment of
the exercise price in full, together with all applicable transfer taxes, if
any.
¨
The undersigned hereby elects to purchase ________ shares of Common Stock (the
“Exercise
Shares”) of Northwest
Biotherapeutics,
Inc. (the
“Company”)
pursuant to the terms of the net exercise provisions set forth in
Section 2.1 of the attached Warrant, and shall tender payment of all
applicable transfer taxes, if any.
(2) Please
issue a certificate or certificates representing said Exercise Shares in the
name of the undersigned or in such other name as is specified
below:
________________________
(Name)
________________________
________________________
(Address)
(3) The
undersigned represents that (i) the aforesaid Exercise Shares are being acquired
for the account of the undersigned for investment and not with a view to, or for
resale in connection with, the distribution thereof and that the undersigned has
no present intention of distributing or reselling such shares, except in
accordance with applicable federal and state securities laws; (ii) the
undersigned is aware of the Company’s business affairs and financial condition
and has acquired sufficient information about the Company to reach an informed
and knowledgeable decision regarding its investment in the Company; (iii) the
undersigned is experienced in making investments of this type and has such
knowledge and background in financial and business matters that the undersigned
is capable of evaluating the merits and risks of this investment and protecting
the undersigned’s own interests; (iv) the undersigned understands that Exercise
Shares issuable upon exercise of this Warrant have not been registered under the
Securities Act of 1933, as amended (the “Securities
Act”), by reason of a specific exemption from the registration provisions
of the Securities Act, which exemption depends upon, among other things, the
bona fide nature of the investment intent as expressed herein, and, because such
securities have not been registered under the Securities Act, they must be held
indefinitely unless subsequently registered under the Securities Act or an
exemption from such registration is available; (v) the undersigned is aware that
the aforesaid Exercise Shares may not be sold pursuant to Rule 144 adopted under
the Securities Act unless certain conditions are met and until the undersigned
has held the shares for the number of years prescribed by Rule 144, that among
the conditions for use of the Rule is the availability of current information to
the public about the Company; and (vi) the undersigned agrees not to make any
disposition of all or any part of the aforesaid shares of Exercise Shares unless
and until there is then in effect a registration statement under the Securities
Act covering such proposed disposition or unless such transaction is in
compliance with applicable federal and state securities laws.
(Date)
|
(Signature)
|
|
(Print
name)
|
1.
ASSIGNMENT
FORM
(To
assign the foregoing Warrant, execute this form and supply required information.
Do not use this form to purchase shares.)
For Value
Received, the foregoing Warrant and all rights evidenced thereby are
hereby assigned to
Name:
|
|
(Please
Print)
|
|
Address:
|
|
(Please
Print)
|
Dated:
__________, 20__
Holder’s
|
|
Signature:
|
|
Holder’s
|
|
Address:
|
NOTE: The signature to this
Assignment Form must correspond with the name as it appears on the face of the
Warrant, without alteration or enlargement or any change whatever. Officers of
corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing
Warrant.
2.